Sort   by:  
 Page size 
0
UnknownHealthcare <b>bricolage in Europe's superdiverse neighbourhoods: a mixed methods study.
Not available
S-EPMC6805362 | biostudies-literature
0
UnknownmHealth and the management of chronic conditions in rural areas: a note of caution from southern India.
Not available
S-EPMC5359738 | biostudies-other
0
Unknown'If there were doctors who could understand our pro<b>blems, I would already be better': dissatisfactory health care and marginalisation in superdiverse neighbourhoods.
Not available
S-EPMC7318273 | biostudies-literature
1K
Other,MultiomicsWellcome Trust Sanger Institute
The Wellcome Trust Sanger Institute (WTSI), Hinxton, Cam<b>bridge, UK is a not-for-profit research organisation and a world famous Genome Centre dedicated to the sequencing and functional analysis of genomes. The Sanger Institute underpins biological and medical research worldwide through large-scale an...
EGAO00000000020 | EGA
0
UnknownSuperdiversity, migration and use of internet-<b>based health information - results of a cross-sectional survey conducted in 4 European countries.
Not available
S-EPMC7439663 | biostudies-literature
0
UnknownSimilarities in <b>butterfly emergence dates among populations suggest local adaptation to climate.
Not available
S-EPMC4744750 | biostudies-literature
0
UnknownGenomic anatomy of the Tyrp1 (<b>brown) deletion complex.
Not available
S-EPMC1450144 | biostudies-literature
0
GenomicsTRACERx esophageal adenocarcinoma
Data Access Committee EGAC00001000340
EGAC00001000340 | EGA
0
Genomicsena-DATASET-UCL-14-05-2015-18:11:37:007-120 - samples
This dataset contains whole exome data from 8 esophageal adenocarcinoma tumors, that has <b>been subjected to multiregion sequencing, ranging from 3-8 regions per tumor. In total, 40 tumor samples and 8 normal blood samples have been sequenced on Illumina HiSeq 2500 at a median dept of 90x.
EGAD00001001364 | EGA
0
GenomicsTracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy
...arcinomas (EACs) are associated with dismal prognosis. Deciphering the evolutionary histories of this disease may shed light on therapeutically tracta<b>ble targets and reveal changing mutational processes during the disease course and following neoadjuvant chemotherapy (NAC). We exome sequenced 40 tumo...
EGAS00001001254 | EGA
Sort   by:  
 Page size